Is BridgeBio Oncology Therapeutics Inc. (BBOT) a Buy, Sell, or Hold?
BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOT
$8.41 USD
-$0.41 (-4.65%)
- Volume
- 457.22K
- Average Volume
- 472.3K
- Market Capitalization
- $673.7M
- P/E Ratio
- -1.47
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $14.87
- Year Low
- $7.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.16
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
-63.4% DOWNSIDE
$23.00 Price Target
UPSIDE/DOWNSIDE HIGH
-63.4% DOWNSIDE
$23.00 Price Target High
UPSIDE/DOWNSIDE LOW
-63.4% DOWNSIDE
$23.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | John Newman | $23 | $7.66 | 2026-05-11 05:15 AM | 200.3% |
| Stifel Nicolaus | Laura Prendergast | $23 | $10.84 | 2026-02-10 04:13 PM | 112.2% |
| H.C. Wainwright | Robert Burns | $27 | $9.73 | 2025-09-15 06:15 AM | 177.5% |
| Piper Sandler | Biren Amin | $21 | $9.7 | 2025-08-15 07:03 AM | 116.5% |